Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Free Cash Flow (2020 - 2025)

Journey Medical's Free Cash Flow history spans 6 years, with the latest figure at -$6.3 million for Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow fell 382.43% year-over-year to -$6.3 million, compared with a TTM value of -$12.4 million through Dec 2025, down 36.31%, and an annual FY2025 reading of -$12.4 million, up 48.44% over the prior year.
  • Free Cash Flow for Q4 2025 was -$6.3 million at Journey Medical, down from -$2.4 million in the prior quarter.
  • The five-year high for Free Cash Flow was $18.7 million in Q3 2023, with the low at -$19.1 million in Q1 2022.
  • Average Free Cash Flow over 5 years is -$2.9 million, with a median of -$3.3 million recorded in 2021.
  • Year-over-year, Free Cash Flow crashed 1504.56% in 2022 and then surged 357.44% in 2023.
  • Tracing DERM's Free Cash Flow over 5 years: stood at -$3.2 million in 2021, then dropped by 19.65% to -$3.8 million in 2022, then plummeted by 330.66% to -$16.5 million in 2023, then surged by 113.47% to $2.2 million in 2024, then crashed by 382.43% to -$6.3 million in 2025.
  • Per Business Quant, the three most recent readings for DERM's Free Cash Flow are -$6.3 million (Q4 2025), -$2.4 million (Q3 2025), and -$942000.0 (Q2 2025).